• 82°

Guest Opinion: Patent-busting will not get the world vaccinated

By Michael Rosenblatt

Today, 40 percent of Americans have had a shot against Covid-19. Globally, coronavirus inoculations have saved millions of lives and will save tens of millions more.

Drug companies developed the new vaccines with impressive speed, thanks to years of earlier research and billions in private financing. And the system that gave us these shots depends entirely on strong intellectual property rights.

These same protections will be critical when we face the next pandemic. But unfortunately, they may not be there if India and South Africa get their way.

Right now, the World Trade Organization is considering a petition from India and South Africa to waive intellectual property rights globally for Covid-19 vaccines and treatments.

Supported by about 100 countries, the petition asserts that patents are blocking access to vaccines. But the barriers they say they’re worried about have already been removed – and there’s no evidence that stripping patent rights would do anything to increase vaccine access.

Consider the licensing and distribution agreements we’ve seen thus far.

Johnson & Johnson promised to allocate up to half a billion doses to low-income countries, largely on a nonprofit basis. And the patent-holders of the three U.S.-approved vaccines – Johnson & Johnson, Moderna and Pfizer – have licensed their intellectual property at no cost.

These and other collaborative deals are speeding vaccine deployment and they wouldn’t be possible without intellectual property rights. Companies don’t share know-how if their innovations can be copied without consequence.

The campaign to gut patents also seems to ignore the highly successful COVAX program, co-led by the World Health Organization, through which other organizations, drug companies and governments, including the United States, are cooperating to distribute doses across the world. Thus far, COVAX had shipped 77 million doses to 127 participants.

The main obstacles to getting shots into arms have nothing to do with intellectual property.

So-called “last mile” delivery is a challenge, given that some Covid-19 vaccines require ultra-cold storage. Suspending patents would accomplish nothing in regions that don’t have robust electricity and industrial freezers.

The biggest hurdle is manufacturing. Vaccine factories worldwide are running at capacity. “It just takes time to scale up,” Serum Institute chief executive Adar Poonawalla recently told The Guardian.

Meanwhile, suspending intellectual property rights could have a devastating downside.

Pharmaceutical research is a tremendous gamble. Most efforts to develop medicines never come to fruition, despite billions of dollars invested over many years.

Intellectual property protections – which assure inventors they’ll have sole right to their creations for a set period of time – offer a chance at a reward in the face of all that risk. By preserving that chance, these rights keep investment into drug research flowing.

Health experts at Duke University estimate that 70 percent of the world’s population could be vaccinated by the end of this year. Let’s not mark this extraordinary achievement by tearing up the system that made it possible. We’re beating this pandemic, but we’re going to need intellectual property rights to fight the next one, too.

Michael Rosenblatt, M.D. is a senior partner at Flagship Pioneering, the former Chief Medical Officer of Merck and the former Dean of Tufts Medical School. He serves as an advisor to Moderna.

FOR MORE COLUMNS AND LETTERS TO THE EDITOR, CHECK OUT OUR OPINION SECTION HERE.

Hyde

Airplane flips after landing at Ocracoke airport

Crime

North Carolina police investigating drive-by shooting that claimed life of 12-year-old

Crime

Virginia man arrested for domestic assault in Rodanthe

News

William B. Umstead Bridge speed limit temporarily lowered for purple martins

Crime

Virginia man arrested in Nags Head after traffic stop

Lifestyles

Outer Banks Anglers Club to hear from artificial reef coordinator at next meeting

Crime

Former North Carolina resident sentenced to prison for bribery, visa fraud, tax charges

Hyde

Drone trial delivers supplies to Ocracoke Island

News

Comments open on proposed Buxton and Avon nourishment projects

Currituck

Shingle Landing Park opens in Moyock

News

Retired magistrate called back to active duty

Lifestyles

New bicycle exhibit opens at Roanoke Island Festival Park

Crime

North Carolina man sentenced to five years in prison, three years of supervised release for firearm charge

Crime

Two men dead after interstate shooting in North Carolina

Lifestyles

Hundreds gather to witness release of two sea turtles at Coquina Beach

News

Major North Carolina hospital systems to require staff to get COVID-19 vaccine

News

Firefighters rescue multiple children from North Carolina house fire

Lifestyles

Outer Banks Community Foundation grant deadline nears

Crime

Cooper announces reward for information on Guilford County murder

Lifestyles

Fascinating fasciation: Roanoke Island garden experiences rare phenomenon

Crime

North Carolina man sentenced to over 17 years in prison for soliciting minors for photos

News

Opioid settlement: North Carolina’s share could be $750M

News

Cooper moves to end North Carolina’s statewide mask mandate

Crime

Uber driver charged with kidnapping, sexually assaulting customer in North Carolina